Cell Stem Cell - Abnormal Calcium Handling Properties Underlie Familial Hypertrophic Cardiomyopathy Pathology in Patient-Specific Induced Pluripotent Stem Cells

Cell Stem Cell - Abnormal Calcium Handling Properties Underlie Familial Hypertrophic Cardiomyopathy Pathology in Patient-Specific Induced Pluripotent Stem Cells

Abnormal Calcium Handling Properties Underlie Familial Hypertrophic Cardiomyopathy Pathology in Patient-Specific Induced Pluripotent Stem Cells

• Summary
• 
• Comments (0)

  To view the full text, please login as a subscribed user or purchase a subscription. Click here to view the full text on ScienceDirect.

• PDF 2.22 MB
• Export Citation
• Permissions

Cell Stem Cell, Volume 12, Issue 1, 101-113, 3 January 2013
Copyright © 2013 Elsevier Inc. All rights reserved.
10.1016/j.stem.2012.10.010

Authors

Feng Lan, Andrew S. Lee, Ping Liang, Veronica Sanchez-Freire, Patricia K. Nguyen, Li Wang, Leng Han, Michelle Yen, Yongming Wang, Ning Sun, Oscar J. Abilez, Shijun Hu, Antje D. Ebert, Enrique G. Navarrete, Chelsey S. Simmons, Matthew Wheeler, Beth Pruitt, Richard Lewis, Yoshinori Yamaguchi, Euan A. Ashley, Donald M. Bers, Robert C. Robbins, Michael T. Longaker, Joseph C. WuSee Affiliations

• Highlights
• Patient-specific iPSC-CMs recapitulate the HCM phenotype at the single-cell level
• iPSC-CMs with the HCM Arg663His mutation have irregular Ca²⁺ handling properties
• Elevation in [Ca²⁺]_i induces both hypertrophy and arrhythmia in iPSC-CMs
• Pharmacological treatment of Ca²⁺ imbalance prevents HCM phenotype development

Summary

Familial hypertrophic cardiomyopathy (HCM) is a prevalent hereditary cardiac disorder linked to arrhythmia and sudden cardiac death. While the causes of HCM have been identified as genetic mutations in the cardiac sarcomere, the pathways by which sarcomeric mutations engender myocyte hypertrophy and electrophysiological abnormalities are not understood. To elucidate the mechanisms underlying HCM development, we generated patient-specific induced pluripotent stem cell cardiomyocytes (iPSC-CMs) from a ten-member family cohort carrying a hereditary HCM missense mutation (Arg663His) in the MYH7 gene. Diseased iPSC-CMs recapitulated numerous aspects of the HCM phenotype including cellular enlargement and contractile arrhythmia at the single-cell level. Calcium (Ca²⁺) imaging indicated dysregulation of Ca²⁺ cycling and elevation in intracellular Ca²⁺ ([Ca²⁺]_i) are central mechanisms for disease pathogenesis. Pharmacological restoration of Ca²⁺ homeostasis prevented development of hypertrophy and electrophysiological irregularities. We anticipate that these findings will help elucidate the mechanisms underlying HCM development and identify novel therapies for the disease.